title: Advantages and disadvantages of biodegradable platforms in drug eluting stents.
abstract: Coronary angioplasty with drug-eluting stent (DES) implantation is currently the most common stent procedure worldwide. Since the introduction of DES, coronary restenosis as well as the incidence of target vessel and target lesion revascularization have been significantly reduced. However, the incidence of very late stent thrombosis beyond the first year after stent deployment has more commonly been linked to DES than to bare-metal stent (BMS) implantation. Several factors have been associated with very late stent thrombosis after DES implantation, such as delayed healing, inflammation, stent mal-apposition and endothelial dysfunction. Some of these adverse events were associated with the presence of durable polymers, which were essential to allow the elution of the immunosuppressive drug in the first DES designs. The introduction of erodable polymers in DES technology has provided the potential to complete the degradation of the polymer simultaneously or immediately after the release of the immunosuppressive drug, after which a BMS remains in place. Several DES designs with biodegradable (BIO) polymers have been introduced in preclinical and clinical studies, including randomized trials. In this review, we analyze the clinical results from 6 observational and randomized studies with BIO polymers and discuss advantages and disadvantages of this new technology.
authors.affiliation: Agustina Rodriguez-Granillo, Center for Advanced Biotechnology and Medicine, Rutgers University, New Jersey, NJ 08854, United States.
authors.forename: Agustina
authors.initials: A
authors.lastname: Rodriguez-Granillo
authors.forename: Bibiana
authors.initials: B
authors.lastname: Rubilar
authors.forename: Gaston
authors.initials: G
authors.lastname: Rodriguez-Granillo
authors.forename: Alfredo E
authors.initials: AE
authors.lastname: Rodriguez